首页> 外国专利> COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A MTOR INHIBITOR.

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A MTOR INHIBITOR.

机译：无糖化的CD20抗体与MTOR抑制剂的联合治疗。

页面导航

摘要
著录项
相似文献

摘要

The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with a m TOR inhibitor for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody and a mTOR inhibitor such as Temsirolimus or Everolimus.

机译：本发明涉及岩藻糖基化抗CD20抗体与am TOR抑制剂的组合疗法，用于治疗癌症，尤其涉及表达CD20的癌症与岩藻糖基化的人源化B-Ly1抗体和mTOR抑制剂，例如替莫罗莫司的组合疗法。或依维莫司。

著录项

公开/公告号MX342590B

专利类型
公开/公告日2016-10-05

原文格式PDF
申请/专利权人 ROCHE GLYCART AG;
展开▼

申请/专利号MX20120012118
发明设计人 KLEIN CHRISTIAN;HERTING FRANK;
展开▼

申请日2011-04-21
分类号A61K39/395;A61K31;
国家 MX
入库时间 2022-08-21 14:23:58

相似文献

专利
外文文献
中文文献